MSB 2.10% $1.17 mesoblast limited

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-75

  1. 15,455 Posts.
    lightbulb Created with Sketch. 5535
    If these people have already made it to ICU with COVID-19 then the current drugs and treatments touted on here by some haven't done their job ... once someone reaches the ICU with COVID-19 it is too late for treatments like monoclonal antibodies, Pfizer Pill and Merck Pill ...

    ..... time for new treatments and new trials IMO so hurry up and get the show on the road SI and the Mesoblast team (and the funding organisation cause I ain't wanting a CR for this to happen) ...


    https://thehill.com/policy/healthcare/589570-icus-nearing-capacity-in-19-states-cnn

    ICUs nearing capacity in at least 18 states

    01/13/22 11:50 AM EST
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.